Stellar Bio Systems, Inc.

Stellar Bio Systems, Inc. — FDA 510(k) Submissions

Stellar Bio Systems, Inc. has submitted 7 FDA 510(k) premarket notifications since 1988, of which 7 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Anti-dna Indirect Immunofluorescent Solid Phase, Epstein-barr Virus, Other, Antigen, Cf (including Cf Control), Cytomegalovirus, Antiserum, Fluorescent, Epstein-barr Virus, Antisera, Fluorescent, Herpesvirus Hominis 1,2 . Use the specialty filter in the sidebar to narrow results.